Filing Flows › Stepan (SCL) › Q2 2026
Stepan (SCL) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 5, 2026
Stepan (SCL) reported revenue of $684M for the second quarter 2026 (Q2 2026), +15% from a year earlier and +13% from the quarter before. Operating margin was 5.4%, net earnings $22.9M (3.3% of revenue).
Stepan, Q2 2026: revenue $684M (+15% year over year), operating margin 5.4%, net earnings $22.9M, operating cash flow $8.4M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $684M | +13% | +15% |
| Gross profit | $100M | +54% | +39% |
| Operating profit | $37.2M | — | +107% |
| Net earnings | $22.9M | — | +102% |
| Operating cash flow | $8.4M | -51% | -25% |
What changed
Revenue was $684.1M in Q2 2026, up 15% year over year and up 13% from the previous quarter. Surfactants was the largest line at 71% of revenue. Surfactants added $72.4M year over year (up 18%), 81% of the total change.
Gross margin was 14.6%, up 2.5 points from Q2 2025. Operating profit was $37.2M, a 5.4% margin (up 2.4 points year over year). Of the extra revenue versus Q2 2025, 22% reached operating profit, above the 3% margin then. Operating expenses grew 16% against revenue growth of 15%. The fastest-growing cost line was Other operating costs (+44%). Net earnings were $22.9M, up 102% year over year. The effective tax rate was 29.6%.
Operating cash flow was $8.4M (down 25% year over year), 37% of net earnings. Non-cash charges added back $30.9M of depreciation and amortization and $2.1M of share-based compensation. Working capital and other items used $47.6M. Capital expenditures of $23.4M exceeded it, leaving free cash flow of −$15.0M.
Questions
What was Stepan's revenue in the second quarter 2026?
Stepan (SCL) reported revenue of $684M for the second quarter 2026 (Q2 2026), +15% from a year earlier and +13% from the quarter before.
Was Stepan profitable in the second quarter 2026?
Operating profit was $37.2M (5.4% of revenue) and net earnings $22.9M.
Source: Stepan 10-Q on SEC EDGAR.